Showing 1191-1200 of 23044 results for "".
Invasive Fungal Infections: More Common Than You Think
https://reachmd.com/programs/cme/invasive-fungal-infections-more-common-than-you-think/14808/Where do we stand in the battle with invasive fungal infections? Find out why we’re losing ground and how to fight back against the fungus among us.An Oncologist’s Perspective from Seattle, Epicenter of America’s First COVID-19 Outbreak
https://reachmd.com/programs/covid-19-frontlines/an-oncologists-perspective-from-seattle-epicenter-of-americas-first-covid-19-outbreak/11383/Only two miles separate an oncology center and the long-term care facility where COVID-19 was first diagnosed. Here’s how the center has responded.Spotlight on Europe: Adapting the Evidence
https://reachmd.com/programs/cme/spotlight-on-europe-adapting-the-evidence/39808/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
https://reachmd.com/programs/cme/safety-of-cdk46-inhibitors-anticipation-prevention-and-management-of-adverse-events/39799/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Spotlight on Asia-Pacific: Practice Beyond Borders
https://reachmd.com/programs/cme/spotlight-on-asia-pacific-practice-beyond-borders/39810/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Spotlight on Latin America: Closing the Gap
https://reachmd.com/programs/cme/spotlight-on-latin-america-closing-the-gap/39809/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Progressive Multiple Sclerosis: Functional, Anatomic, and Biologic Tools to Assess Disability Progression and Improve Patient Outcomes
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/progressive-multiple-sclerosis-functional-anatomic-and-biologic-tools-to-assess-disability-progression-and-improve-patient-outcomes/33143/An enhanced ability to quantify multiple sclerosis disease progression is key for timely optimization of treatment and risk mitigation of worsening disability.The Nation's Uninsured: Part 1
https://reachmd.com/programs/conference-coverage/the-nations-uninsured-part-1/3785/The first of two programs consisting of excerpts of a panel discussion examining the issues surrounding healthcare coverage for millions of uninsured Americans. The panel was presented by U.S. News and World Report's National Issues Briefing, in association with the American Medical Association. PaWhen Topicals Fail: The New IPC Consensus Every Clinician Should Know
https://reachmd.com/programs/cme/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/Review IPC’s 2025 consensus guidance on reclassifying psoriasis severity and redefining failure of topical therapies.